In 2007, Steven Nissen, chair of cardiology at the Cleveland Clinic, pooled studies found on that site to produce a New England Journal of Medicine article that started a firestorm of controversy around the pill, then the best-selling diabetes medicine in the world, that eventually resulted in its sales dropping to close to nothing.

FORBES: With Transparency Pledge, Glaxo Makes Promises No Other Drug Company Has